0001209191-17-041215.txt : 20170621 0001209191-17-041215.hdr.sgml : 20170621 20170621170100 ACCESSION NUMBER: 0001209191-17-041215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2065821600 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN ANTHONY B CENTRAL INDEX KEY: 0001239241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 17923374 MAIL ADDRESS: STREET 1: C/O VENROCK ASSOCIATES STREET 2: 30 ROCKEFELLER PLAZA RM 5508 CITY: NEW YORK STATE: NY ZIP: 21264957 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-20 0 0001594864 Juno Therapeutics, Inc. JUNO 0001239241 EVNIN ANTHONY B C/O 307 WESTLAKE AVENUE N STE 300 SEATTLE WA 98109 1 0 0 0 Common Stock 2017-06-20 4 P 0 9000 24.40 A 66301 D This transaction was executed in multiple trades at prices ranging from $24.33 to $24.48. The price reported above reflects the weighted average purhase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Zachary D. Hale, attorney-in-fact 2017-06-21